Prosecution Insights
Last updated: August 16, 2026

Scientia Vascular Inc.

6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (83%)
1
Medium (17%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (17%)
Multi-statute (no §101)5 (83%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
83% of docket
1
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LONG, SARAH A 1 60.5% +42.5%
TEJANI, ANKIT D 1 81.0% +16.9%
SCHMIDT, EMILY LOUISE 1 58.5% +36.7%
EISEMAN, ADAM JARED 1 55.1% +27.0%
THOMAN, EVELYN ANNE 1
VU, QUYNH-NHU HOANG 1 68.3% +27.5%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18842983 SYSTEMS AND METHODS FOR PULMONARY EMBOLI REMOVAL LONG, SARAH A 1d overdue
18218974 EXTENDABLE LUMEN CATHETER DEVICE VU, QUYNH-NHU HOANG 22d
18634267 SOFT-TIP INTRAVASCULAR DEVICES TEJANI, ANKIT D
18391432 INTRAVASCULAR DEVICE WITH A MATCHED DIAMETER CORE WIRE JOINT EISEMAN, ADAM JARED
18374564 MICROFABRICATED INTRAVASCULAR DEVICE FOR ASPIRATION PROCEDURES THOMAN, EVELYN ANNE

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18842983 SYSTEMS AND METHODS FOR PULMONARY EMBOLI REMOVAL LONG, SARAH A 1d overdue
18218974 EXTENDABLE LUMEN CATHETER DEVICE VU, QUYNH-NHU HOANG 22d
18634267 SOFT-TIP INTRAVASCULAR DEVICES TEJANI, ANKIT D
18633424 INTERLOCK ASSEMBLY FOR A MICROCATHETER DEVICE SCHMIDT, EMILY LOUISE
18391432 INTRAVASCULAR DEVICE WITH A MATCHED DIAMETER CORE WIRE JOINT EISEMAN, ADAM JARED

Top Art Units

Art UnitApps
3783 2
3771 1
3796 1
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18842983 SYSTEMS AND METHODS FOR PULMONARY EMBOLI REMOVAL LONG, SARAH A 3771 §102§103 Final Rejection 1d overdue Pending Aug 30, 2024
18634267 SOFT-TIP INTRAVASCULAR DEVICES TEJANI, ANKIT D 3796 §102§103Other Non-Final OA Pending Apr 12, 2024
18633424 INTERLOCK ASSEMBLY FOR A MICROCATHETER DEVICE SCHMIDT, EMILY LOUISE §102 Non-Final OA Pending Apr 11, 2024
18391432 INTRAVASCULAR DEVICE WITH A MATCHED DIAMETER CORE WIRE JOINT EISEMAN, ADAM JARED 3791 §102§103 Non-Final OA Pending Dec 20, 2023
18374564 MICROFABRICATED INTRAVASCULAR DEVICE FOR ASPIRATION PROCEDURES THOMAN, EVELYN ANNE 3783 §103§112 Non-Final OA Pending Sep 28, 2023
18218974 EXTENDABLE LUMEN CATHETER DEVICE VU, QUYNH-NHU HOANG 3783 §102§103§112 Final Rejection 22d Pending Jul 06, 2023

Managing Scientia Vascular Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month